Johnson & Johnson’s coronavirus jab rolled out after backing from European Medicines Agency
EU member states are starting to administer Johnson & Johnson’s coronavirus vaccine after Europe’s drug regulator this week backed the single-dose shot, with several expected to impose age restrictions, as with the AstraZeneca jab.
Spain’s regional health authorities began using the shot on Thursday for people aged 70 to 79, two days after the European Medicines Agency (EMA) announced a possible link to a rare clotting disorder but stressed the shot’s benefits outweighed the risks.
